Equities
Basic MaterialsChemicals
  • Price (GBX)325.20
  • Today's Change-1.60 / -0.49%
  • Shares traded408.81k
  • 1 Year change-30.87%
  • Beta0.8132
Data delayed at least 20 minutes, as of Jan 18 2019 16:52 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Scapa Group plc is a United Kingdom-based global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets. The Company has a global footprint, with production sites in Asia, Europe and the United States. The Company conducts the activities through two distinct and separate businesses: Healthcare and Industrial business units. The Company’s subsidiary Scapa Healthcare is a outsource partner in the advanced wound care, consumer wellness, medical device fixation and drug delivery markets. Scapa Industrial operates across a diverse range of market segments throughout Europe, North America and Asia, through the two business models of engineered products and commercial products.

  • Revenue in GBP (TTM)286.60m
  • Net income in GBP18.60m
  • Incorporated1964
  • Employees1.31k
  • Location
    Scapa Group PLCManchester RoadASHTON-UNDER-LYNE OL7 0EDUnited KingdomGBR
  • Phone+44 16 1301 7400
  • Fax+44 16 1301 7591
  • Websitehttp://www.scapa.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SCPA:LSE since
announced
Transaction
value
BioMed Laboratories LLCDeal completed26 Mar 201826 Mar 2018Deal completed-32.36%32.00m
Data delayed at least 20 minutes, as of Jan 18 2019 16:52 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
James Cropper PLC99.17m3.13m111.29m524.0035.554.8319.081.120.32780.327810.412.411.42--4.87--4.475.056.066.98--54.073.153.371.515.160.323531.694.283.98-11.6836.22-13.8311.31
Exacompta Clairefontaine SA528.94m9.57m111.84m3.12k11.680.32043.100.21159.599.59529.68349.610.8382.024.04195,666.301.521.692.022.2935.5436.491.811.851.4912.380.261818.29-0.02612.60-6.83--1.2740.11
Rottneros AB192.22m17.38m116.15m306.006.650.95434.470.60421.321.3214.649.221.023.115.237,421,927.009.226.3311.218.1151.3446.579.045.251.7714.530.219271.7810.525.88-10.94--35.97--
Iberpapel Gestion SA194.96m22.32m307.89m289.0013.091.439.701.582.412.4120.7322.150.62975.435.61759,113.407.215.458.046.4060.6259.7111.457.215.2658.150.232637.967.510.084813.935.64-25.6917.55
CPH Chemie Papier Holding AG391.72m32.05m390.81m1.06k12.221.286.960.99776.836.8383.5065.160.7335----492,810.606.00-8.167.11-9.40100.7833.438.17-12.43--4.330.00--8.03-0.7868307.1914.6724.18--
Duni AB406.13m26.42m426.23m2.48k16.142.009.911.056.536.53100.4352.680.92594.845.901,998,307.006.127.588.7110.2727.2728.626.617.681.4628.410.375870.133.983.89-0.903621.1615.567.39
IG Design Group PLC366.22m16.67m458.68m1.95k23.852.7119.521.250.24570.24575.372.161.063.192.41187,422.705.185.7113.119.2721.5219.454.873.160.765922.610.370722.305.317.7840.3631.8434.53--
Miquel y Costas & Miquel SA217.12m33.00m460.73m799.0014.141.979.882.121.191.197.838.530.66091.265.49307,891.1010.049.0411.7610.6166.3960.8715.2014.141.40--0.209730.206.644.058.306.23-18.8915.86
Scapa Group plc286.60m18.60m502.22m1.31k27.743.6317.321.750.11730.11731.810.89661.22--5.40219,113.207.955.1910.597.21--39.966.493.911.1225.250.118529.014.266.9033.5281.299.4636.85
Semapa - Sociedade Invest Gestao SGPS SA1.90bn123.45m1.08bn6.01k8.721.482.880.56971.731.7326.7310.230.5454.347.68356,830.005.414.167.765.9935.4932.669.938.290.76415.500.613133.954.342.088.04-0.38599.997.73
Altri SGPS SA669.32m131.06m1.25bn705.009.563.197.031.870.72480.72483.702.170.5663.716.361,075,712.0011.086.2814.498.8266.8759.7219.5812.511.3514.810.611260.038.814.1624.8012.9841.7453.92
Data as of Jan 18 2019. Currency figures normalised to Scapa Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

49.02%Per cent of shares held by top holders
HolderShares% Held
Octopus Investments Ltd.as of 18 Sep 201814.91m9.65%
Capital Research & Management Co. (World Investors)as of 18 Sep 201812.19m7.89%
Paradice Investment Management LLCas of 02 Oct 20187.89m5.11%
Investec Wealth & Investment Ltd.as of 06 Nov 20187.70m4.99%
River & Mercantile Asset Management LLPas of 28 Apr 20157.23m4.68%
Merian Global Investors (UK) Ltd.as of 28 Apr 20156.49m4.21%
Discretionary Unit Fund Managers Ltd.as of 18 Sep 20186.26m4.05%
Hargreave Hale Ltd.as of 18 Sep 20186.01m3.89%
Henderson Global Investors Ltd.as of 02 Oct 20183.60m2.33%
Rathbone Investment Management Ltd.as of 02 Oct 20183.42m2.21%
More ▼
Data from 31 Dec 2016 - 31 Dec 2018Source: FactSet Research Systems Inc.
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.